North American Biliary Stricture Management Strategies in Children After Liver Transplantation: A Multicenter Analysis From the Society of Pediatric Liver Transplantation (SPLIT) Registry.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
05 2022
Historique:
revised: 12 11 2021
received: 30 08 2021
accepted: 22 11 2021
pubmed: 28 11 2021
medline: 21 4 2022
entrez: 27 11 2021
Statut: ppublish

Résumé

Biliary strictures affect 4%-12% of pediatric liver transplantations. Biliary strictures can contribute to graft loss if left untreated; however, there remains no consensus on the best course of treatment. Study objectives included analyses of outcomes associated with biliary stricture management strategies via percutaneous transhepatic cholangiography (PTC), endoscopic retrograde cholangiopancreatography (ERCP), or surgery. We identified pediatric liver transplantation recipients (2011-2016) with biliary strictures from the Society of Pediatric Liver Transplantation (SPLIT) registry and retrieved imaging, procedural, and operative reports from individual centers. Subanalyses were performed to specifically evaluate PTC and ERCP for "optimal biliary outcome" (OBO), defined as graft survival with stricture resolution and without recurrence or surgery. A total of 113 children with a median follow-up of 3.9 years had strictures diagnosed 100 days (interquartile range, 30-290) after liver transplantation; 81% were isolated anastomotic strictures. Stricture resolution was achieved in 92% within 101 days, more frequently with isolated anastomotic strictures (96%). 20% of strictures recurred, more commonly in association with hepatic artery thrombosis (32%). Patient and graft survival at 1 and 3 years were 99% and 98% and 94% and 92%, respectively. In a subgroup analysis of 79 patients with extrahepatic strictures managed by PTC/ERCP, 59% achieved OBO following a median of 4 PTC, and 75% following a median of 3 ERCP (P < 0.001). Among patients with OBO, those with ERCP had longer time intervals between successive procedures (41, 47, 54, 62, 71 days) than for PTC (27, 31, 36, 41, 48 days; P < 0.001). Allograft salvage was successful across all interventions. Stricture resolution was achieved in 92%, with 20% risk of recurrence. Resolution without recurrence was highest in patients with isolated anastomotic strictures and without hepatic artery thrombosis.

Identifiants

pubmed: 34837468
doi: 10.1002/lt.26379
pii: 01445473-202205000-00016
pmc: PMC10167704
mid: NIHMS1822449
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-833

Subventions

Organisme : AHRQ HHS
ID : K08 HS026510
Pays : United States

Informations de copyright

© 2021 by the American Association for the Study of Liver Diseases.

Références

Gastrointest Endosc. 2018 Feb;87(2):501-508
pubmed: 28757315
Ann Surg. 2007 Aug;246(2):301-10
pubmed: 17667510
Liver Transpl. 2015 Aug;21(8):1082-90
pubmed: 25991054
JAMA Pediatr. 2017 Jan 02;171(1):e163470
pubmed: 27820621
Liver Transpl. 2021 Feb;27(2):257-263
pubmed: 32652804
Transplantation. 2016 Sep;100(9):1944-54
pubmed: 27362317
J Pediatr. 2012 May;160(5):820-6.e3
pubmed: 22192813
J Pediatr. 2020 Nov;226:195-201.e1
pubmed: 32585237
Transplant Rev (Orlando). 2017 Jul;31(3):207-217
pubmed: 28427741
Pediatr Transplant. 2014 Dec;18(8):822-30
pubmed: 25263826
Pediatr Transplant. 2019 Nov;23(7):e13551
pubmed: 31313460
Pediatr Transplant. 2017 Feb;21(1):
pubmed: 27796068
Liver Transpl. 2020 Jan;26(1):45-56
pubmed: 31509650
Pediatr Transplant. 2016 Aug;20(5):647-51
pubmed: 27239056
Langenbecks Arch Surg. 2019 Nov;404(7):875-883
pubmed: 31327033
JAMA Pediatr. 2019 Jan 1;173(1):29-36
pubmed: 30398535
Am J Transplant. 2021 Feb;21 Suppl 2:208-315
pubmed: 33595192
Liver Transpl. 2014 Aug;20(8):893-903
pubmed: 24809592
Pediatr Transplant. 2020 Feb;24(1):e13605
pubmed: 31680409
Clin Transplant. 2019 Jun;33(6):e13570
pubmed: 31006158

Auteurs

Pamela L Valentino (PL)

Section of Gastroenterology and HepatologyDepartment of Pediatrics Yale University School of Medicine New Haven CT Department of Statistics and Data Science Yale University New Haven CT Department of Pediatrics Yale University School of Medicine New Haven CT Transplant and Regenerative Medicine CenterHospital for Sick Kids University of Toronto Toronto ON Canada Icahn School of Medicine at Mount Sinai New York NY Children's Hospital Colorado and the University of Colorado School of Medicine Aurora CO Division of Pediatric Gastroenterology, Hepatology and Liver TransplantationAdventHealth for Children AdventHealth Transplant Institute Orlando FL Emory University School of Medicine Atlanta GA Division of Hepatology Holtz Children's HospitalUniversity of Miami Miami FL Department of PediatricsFeinberg School of Medicine Northwestern University Chicago IL Department of Radiology The Royal Marsden NHS Foundation Trust London UK MedStar Georgetown Transplant Institute Washington DC Hillman Center for Pediatric Transplantation Children's Hospital of Pittsburgh Pittsburgh PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH